Japan· JP-3231400G1025

ブドウ糖

A glucose product containing ブドウ糖, registered in Japan by 大塚製薬工場, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

On Japan’s NHI price listATC B05CX01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedブドウ糖ATCB05CX01REGISTER NO.JP-3231400G1025PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Glucose is registered in 3 of 19 countries.

Countries holding a registration under ATC B05CX01 (glucose), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 2 of them publish a price we can compare per daily dose

Glucose · ATC B05CX01

3 / 19 countries

  • Belgiumprice
  • Japan
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ブドウ糖
Manufacturer
大塚製薬工場
Country
Japan (JP)
ATC code
B05CX01
ATC class
Glucose
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for glucose.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glucose · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • Fludeoxyglucose (18F)V09IX04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glucose in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glucose products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Glucose B. Braun, Glucose Fresenius
  • Belgium · Glucose Aguettant, Glucose B. Braun
  • Bulgaria · Глюкоза Бакстер, Глюкоза Браун
  • Cyprus · Dextrose /Demo 20%, Dextrose Demo
  • Czechia · Ardeanutrisol G, Glucose Fresenius Kabi
  • Germany · Glucose B. Braun, Glucose Laboratoire Aguettant
  • Denmark · Glucos B. Braun, Glucos Fresenius Kabi
  • Estonia · Glucose B. Braun, Glucose B.Braun
  • Spain · Dextrosa Fresenius Kabi, Freeflex Glucosa
  • Finland · Glucos B. Braun, Glucos Fresenius Kabi
  • France · Glucose Aguettant, Glucose B. Braun
  • United Kingdom (Northern Ireland) · Glucose Aguettant, Glucose B. Braun Melsungen
  • Greece · Dextrose Cooper, Dextrose Fresenius
  • Croatia · Glukoza B. Braun, Glukoza Fresenius Kabi
  • Hungary · Glucose B. Braun, Glucosum Pannonpharma
  • Ireland · Glucose, Glucose Baxter Holding
  • Iceland · Glucos Fresenius Kabi, Glucos Viaflo Baxter
  • Italy · Glucorange, Glucosio
  • Lithuania · Glucose B. Braun, Glucose B.Braun
  • Luxembourg · Glucose, Glucose B. Braun
  • Latvia · Glucose B.Braun, Glucose Fresenius
  • Malta · Dextrose Vioser, Glucose Baxter Holding
  • Netherlands · Glucose, Glucose 5% G/V
  • Norway · Glucos B. Braun, Glucos Fresenius Kabi
  • Poland · Gluco Test, Glucosi Baxter
  • Portugal · Glucosada, Glucosada Grifols
  • Romania · Dextrose Vioser, Glucose B Braun
  • Sweden · Glucos B. Braun, Glucos Fresenius Kabi
  • Slovenia · Glukoza Baxter, Glukoza Braun
  • Slovakia · Glucose Fresenius Kabi, Glucose Intravenous Infusion B.P. Bieffe

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5a0fb09-b93f-4bb2-b45c-d358ee41b218
GET /v1/drugs/d5a0fb09-b93f-4bb2-b45c-d358ee41b218?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "5%100mL1キット",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3231400G1025",
  "category": "注射薬",
  "price_yen": 235,
  "generic_name": "ブドウ糖",
  "product_name_jp": null,
  "therapeutic_class": "3231",
  "transitional_expiry": null
}

See everything about glucose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.